Tag: Cancer: Bladder
ASS1 Loss Identified in Invasive Bladder Cancer
ASS1-deficient cells were preferentially sensitive to ADI-PEG 20, as shown by reduced cell viability
Thromboembolic Events Common With Chemo for Bladder Cancer
Findings in patients with muscle invasive bladder cancer who undergo neoadjuvant chemotherapy
Bladder Cancer Risk Correlates With Low Serum Vitamin D
Researchers find that bladder epithelial cells activate and respond to vitamin D
Factors ID’d for Recurrence After Radical Cystectomy
Pathological tumor characteristics mainly predict recurrence after robot-assisted radical cystectomy
Study Looks at Recurrence After Laparoscopic Radical Cystectomy
During first 24 months, 8.7 percent of patients with favorable pathological characteristics had progressed
Sex Disparities in Chemo Use for Advanced Bladder Cancer
Women have lower median overall survival, even after adjustment for administration of chemo
Patient Experience Linked to Urologic CA Surgical Outcomes
Less prolonged hospitalization, fewer nursing-sensitive complications in high-performing hospitals
ASCO: Immunotherapy Beneficial in Advanced Bladder Cancer
About a quarter of older patients deemed too frail for chemo responded to atezolizumab
FDA Approves Tecentriq to Treat Urothelial Carcinoma
FDA also approves a companion test to detect PD-L1 protein expression levels in patients
Well Water a Suspected Cause of Bladder Cancer in New England
Researchers believe arsenic exposure might contribute to higher-than-normal rates
